This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: René P Traber: Innovator in Cyclosporin Fermentation Process
Introduction
René P Traber is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cyclosporin derivatives. His work has implications for the treatment and prevention of AIDS and related disorders.
Latest Patents
René P Traber holds a patent for a novel cyclosporin fermentation process. This patent focuses on nonimmunosuppressive, cyclophilin-binding cyclosporins that are beneficial in treating AIDS and AIDS-related disorders. The patent includes innovative derivatives of cyclosporin that are modified at the 4- and/or 5-positions, showcasing his commitment to advancing medical science.
Career Highlights
Throughout his career, René P Traber has been associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other talented professionals in the field, further enhancing his contributions to pharmaceutical innovations.
Collaborations
René P Traber has worked alongside esteemed colleagues such as Soo Young Ko and Hans Kobel. These collaborations have played a crucial role in the development of his patented processes and have contributed to the overall success of their projects.
Conclusion
René P Traber's innovative work in the field of cyclosporin fermentation processes highlights his significant impact on medical advancements. His contributions continue to influence the treatment of critical health issues, demonstrating the importance of innovation in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile